Skip to main content

Table 4 Expression of EZH2 in benign lesions and associated with invasive carcinoma

From: EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features

Pathologic feature

 

EZH2 score

 
 

Total N

≤3

>3

p value

Adenosis

10

100 % (10/10)

0

p < 0.001

UDH

10

100 % (10/10)

0

 

DCIS associated with high grade triple-negative carcinoma

20

10 % (2/20)

90 % (18/20)

 

DCIS associated with low to moderate grade non-triple-negative carcinoma

20

45 % (9/20)

55 % (11/20)